Janssen Sciences Ireland UC

Politician(s) lobbied: Peter Burke (Minister), Department of Enterprise, Trade and Employment; Jennifer Carroll MacNeill (Minister), Department of Health; John Newham (Assistant Secretary), Department of Enterprise, Trade and Employment; Muiris O’Connor (Assistant Secretary), Department of Health; Niall Redmond (Assistant Secretary), Department of Health

Intent: To encourage interdepartmental collaboration on policy files relevant to the life sciences sector and to embed this in the upcoming national life sciences strategy::To include industry representation in relevant EU policymaking discussions during the EU Presidency.

Methods: Event / Reception

Politician(s) lobbied: Micheál Martin (Taoiseach), Dáil Éireann, the Oireachtas

Intent: To support the prioritisation of competitiveness as a key theme during Ireland's Presidency of the Council of the EU::To encourage implementation of the Draghi report and its recommendations for EU competitiveness ::To promote openness in trade and global supply chains

Methods: Meeting

Politician(s) lobbied: John Lahart (TD), Dáil Éireann, the Oireachtas

Intent: To encourage implementation of the new IPHA Framework Agreement, including better resourcing to enable faster decision-making processes.::To encourage integration of this into the upcoming national life sciences strategy.

Methods: EmailMeeting

Politician(s) lobbied: Deirdre Gillane (Chief of Staff), Department of the Taoiseach; Jim O'Callaghan (Minister), Department of Justice

Intent: To highlight the contribution of J&J to the Irish economy::To seek meetings between senior J&J leaders and Government

Methods: EmailMeeting

Politician(s) lobbied: Cait Moran (Deputy Permanent Representative of Ireland to the European Union), Department of Foreign Affairs

Intent: To ensure J&J alignment and support for Ireland's EU Presidency objectives in H2 2026::To discuss the possibility of an official visit to J&J sites during the Presidency

Methods: Meeting

Politician(s) lobbied: Cait Moran (Deputy Permanent Representative of Ireland to the European Union), Department of Foreign Affairs

Intent: To highlight concerns about the feasibility of plans for implementation of medicine Shortage Prevention Plans::To encourage the giving of consideration of an extended deadline for implementation of SPPs and for revision of the scope in favour of a phased or risk-based approach

Methods: Meeting

Politician(s) lobbied: Micheál Martin (An Taoiseach), Department of the Taoiseach

Intent: To highlight the positive economic and social impact of Johnson & Johnson's presence in Ireland and encourage the maintenance of a positive relationship.

Methods: Informal communication

Politician(s) lobbied: Teresa Costello (Senator), Seanad

Intent: To discuss the challenge of delayed patient access to new medicines and highlight the potential for the new IPHA Framework Agreement to improve access to innovation if implemented::To highlight the potential value of the national strategy for the life sciences and promote integration of patient access objectives

Methods: EmailMeeting

Politician(s) lobbied: Niall Redmond (Assistant Secretary), Department of Health; Derek Tierney (Assistant Secretary), Department of Health; Professor Mary Horgan (Chief Medical Officer), Department of Health

Intent: To welcome and highlight the value of the new IPHA Framework Agreement on Pricing & Supply of Medicines and its potential to improve access to innovation for patients::To encourage collaborative implementation of the Framework Agreement in the coming months and years

Methods: Meeting

Politician(s) lobbied: Verona Murphy (TD), Dáil Éireann, the Oireachtas; Helen McEntee (Minister), Department of Foreign Affairs; Peter Burke (Minister), Department of Enterprise, Trade and Employment; Conor Glynn (Special Adviser), Department of Foreign Affairs; Micheál Martin (Taoiseach), Dáil Éireann, the Oireachtas; Jack Chambers (Minister), Department of Public Expenditure, NDP Delivery and Reform; Maeve von Heynitz (Director General), Department of Foreign Affairs

Intent: To highlight the importance of the new IPHA Framework Agreement on the Supply and Pricing of Medicines and to encourage its implementation by the State in the coming years::To highlight the challenge of delayed patient access to innovative medicines and the potential for improvement through reform and resourcing of the reimbursement system::To welcome progress towards a new national life sciences strategy::To encourage a pro-innovation position on any policy files relevant to the life sciences sector by Ireland during its Presidency of the European Union in H2 2026

Methods: Meeting